Firms

6 Dimensions Capital

6 Dimensions Capital

Hong Kong · Shanghai, China · Boston, United States · San Francisco, United States

6 Dimensions Capital is a China–United States life-sciences venture investment firm formed in May 2017 through the combination of Frontline BioVentures and WuXi Healthcare Ventures. It is distinct from the US science-and-compute firm Dimension founded in 2022. Its primary portfolio includes brain/mental-health platform Haoxinqing, computational drug-discovery company Engine Biosciences and condensate therapeutics company Dewpoint, establishing neuroscience and deep-technology relevance without independent efficacy or regulatory claims. The exact manager is 6 Dimensions Capital Limited, CRD292273 / SEC802-113386; its March30,2026 exempt-reporting-adviser filing confirms two Cayman USD vehicles, 6 Dimensions Capital,L.P. and 6 Dimensions Affiliates Fund,L.P., with 6 Dimensions Capital GP,LLC. The related WuXi Healthcare Ventures Management US LLC filing reports the same vehicles, not extra cash pools. The own December7,2017 final-close announcement states USD533million for the inaugural USD fund family and CNY2.06billion for the inaugural RMB fund. Historical USD1.5billion/RMB10billion aggregate AUM and fundraising targets are excluded from fund-close amounts. The exact RMB legal vehicle and allocation of the USD pooled close between its parallel legal vehicles remain unverified. The currently accessible public website contains an undated roster of 26 distinct investment, finance, venture-partner, affiliate and adviser people, with older titles and duplicate cards; those affiliations are retained as undated published roles, not independently asserted as 2026 employment. March2026 legal director/member affiliations separately confirm Leon Chen, Wei Li, Qingsheng/Ching Zhu, Ge Li and Edward Hu. The filing names CFO Chung Sau Yin; no unsupported exact personal alias is asserted for the published Christina Chung. Founder/chair Ge Li is the WuXi founder, distinguished from the existing Swinburne communications namesake. CStone’s own May9,2018 financing explicitly identifies 6 Dimensions Capital; the historical imported participation was misattributed to the later US Dimension firm. Original Goldilocks importer history is preserved and documented separately; only the native investment manager attribution is corrected. No legal continuity or portfolio-transfer cash with Boyu is assumed.

Founded
2017
Type
Venture capital

Funds4

  • 6 Dimensions RMB Fund I (public closed family; exact legal vehicle unverified)CN¥2.06B
  • 6 Dimensions USD Fund I (Capital LP / Affiliates LP pooled family)$533M
  • 6 DIMENSIONS AFFILIATES FUND,L.P.—
  • 6 DIMENSIONS CAPITAL,L.P.—

Team

Operations and support

Allen ChaoAdviser (undated published roster)
Ching ZhuChing ZhuAffiliate Member (undated published roster); Director and Member, Qingsheng Zhu (March2026 filing)
Christina ChungChristina ChungChief Financial Officer
Colin WangColin WangPartner
Corrine ChenCorrine ChenVice President
Dong WuVenture Partner (undated published roster)
Edward HuEdward HuDirector and Member (March2026 filing)
Erdong HuaErdong HuaPartner
Ge Li WuXi FounderGe Li WuXi FounderDirector and Member (March2026 filing); Founder/Chairman (2017 announcement)
Gregory VerdineGregory VerdineVenture Partner (undated published roster)
Hannes SmárasonHannes SmárasonSenior Managing Director
Hongye SunVenture Partner (undated published roster)
Jason SunAdviser (undated published roster)
Jia SunJia SunAssociate
Jianwei YuanJianwei YuanVice President
Jin WangJin WangVP Finance
Leo YanLeo YanSenior Associate
Leon ChenLeon ChenCEO & Founding Partner; Director and Member (March2026 filing)
Norman ChenNorman ChenVenture Partner (undated published roster)
Qin XieQin XiePartner
Quanlu ZhengAdviser (undated published roster)
Richard LiRichard LiLegal Director
Wei LiAffiliate Member (undated published roster); Director and Member (March2026 filing)
Wei ZhaoWei ZhaoExecutive Director
Xiaoliang Sunney XieAdviser (undated published roster)

Co-investing

WuXi AppTec
Baidu Ventures
EDBI
Nest.Bio Ventures

Investments